Anurag Agarwal, MD
Radiation Oncology · Boca Raton, FLNPI 1962482836
Payments from drug & device makers
Across 100 payments — averaging $78.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novocure Inc.$3K
- Bayer$2K
- Teleflex LLC$361
- Sirtex Medical Inc$351
- Johnson & Johnson$265
- Novartis$263
- plus $2K from 33 others
What the payments were for
- Consulting fees$4,21354%
- Food & beverage$3,61546%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novocure Inc. | 9 | $2,933 |
| Bayer | 8 | $1,839 |
| Teleflex LLC | 2 | $361 |
| Sirtex Medical Inc | 5 | $351 |
| Johnson & Johnson | 5 | $265 |
| Novartis | 17 | $263 |
| Q Biomed Inc. | 1 | $180 |
| Icotec Medical Inc. | 2 | $154 |
| Argon Medical Devices, Inc. | 1 | $151 |
| Abbott | 1 | $141 |
| Boston Scientific | 2 | $132 |
| Cerapedics Inc. | 1 | $113 |
| AstraZeneca | 6 | $110 |
| Brainlab, Inc. | 1 | $97 |
| Amgen | 5 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $52 |
| Eisai Inc. | 3 | $52 |
| Sanofi | 3 | $51 |
| Monteris Medical Corporation | 2 | $50 |
| Ipsen Biopharmaceuticals, Inc | 2 | $41 |
| Pfizer | 2 | $40 |
| Myriad Genetic Laboratories, Inc. | 2 | $34 |
| Progenics Pharmaceuticals, Inc. | 1 | $31 |
| Fortovia Therapeutics, Inc. | 2 | $25 |
| Reflexion Medical, Inc. | 1 | $25 |
| Coherus Oncology, Inc. | 1 | $24 |
| Adaptive Biotechnologies Corporation | 1 | $23 |
| Pharmacosmos Therapeutics Inc. | 1 | $22 |
| Bristol Myers Squibb | 1 | $22 |
| Morphosys, US Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $22 |
| Incyte Corporation | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Advanced Accelerator Applications | 1 | $18 |
| Mirati Therapeutics, Inc. | 1 | $17 |
| Foundation Medicine, Inc. | 1 | $14 |
| Seagen Inc. | 1 | $14 |
| Merck | 1 | $13 |
| Elekta, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Optune$2,652
- Xofigo$1,713
- Barrigel$361
- SIR-Spheres Microspheres$293
- STRONTIUM CHLORIDE Sr-89$180
- Clot Management$151
- icotec BlackArmor Spine System$142
- Mitra Clip system$141
- Erleada$126
- AKEEGA$126
- OPTUNE LUA (NOVOTTF-200T)$122
- I-FACTOR PEPTIDE ENHANCED BONE GRAFT$113
How this compares
$7,828 in reported general payments places this provider in the 80th percentile of 465 radiation oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 25 | $11,477 |
| Dexamethasone | 19 | $348 |
| Tamsulosin Hcl | 24 | $200 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Boca Raton
- Michael KasperBoca Raton$35K
- Charles KunosMiami$3.2M
- Rupesh KotechaMiami$2M
- Alexander EngelmanTampa$1.1M
- John SylvesterLakewood Ranch$999K
- Kamran AhmedTampa$975K
- Michael ChuongMiami$868K
- Tithi BiswasGainesville$640K
- Daniel TrifilettiJacksonville$606K
- Marcus BredelMiami$578K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.